论文部分内容阅读
目的:观察中西医结合治疗慢性阻塞性肺疾病急性加重期的肺功能及其临床疗效。方法:将80例COPD急性发作患者随机分为两组,中西医结合治疗组40例在予以西医常规治疗同时加服加味越婢加半夏汤治疗;对照组40例采用西医常规治疗。观察两组患者肺功能及临床症状、体征改善情况。结果:经过1个疗程的治疗后,两组治疗后第1s呼出气量(FEV1)、用力肺活量(FVC)均较治疗前均有改善,中西医结合治疗组治疗后第1s呼出气量(FEV1)、用力肺活量(FVC)改善与对照组比较有显著性差异(P<0.05)。中西医结合治疗组临床显效12例,好转23例,无效5例,总有效率为87.5%。对照组临床显效6例,好转24例,无效10例,总有效率75.0%。两组总有效率比较,差异有显著性意义(P<0.05)。中西医结合治疗组临床症状及体征改善优于对照组(P<0.05)。结论:中西医结合治疗慢性阻塞性肺疾病急性发作具有良好的临床疗效,并优于西医常规治疗。
Objective: To observe the pulmonary function and its clinical efficacy in treating acute exacerbation of chronic obstructive pulmonary disease with integrated traditional Chinese and western medicine. Methods: Eighty COPD patients with acute exacerbation were randomly divided into two groups. Forty cases in the combination of traditional Chinese and western medicine were treated with routine western medicine plus flavonoids plus Banxiaxia Decoction while 40 cases in control group were treated with routine Western medicine. Lung function and clinical symptoms and signs of two groups were observed. Results: After one course of treatment, the FEV1 and FVC of both groups were improved after treatment. The FEV1, The forced vital capacity (FVC) improvement compared with the control group had significant difference (P <0.05). Integrative Medicine group of clinical significant in 12 cases, improved in 23 cases, 5 cases, the total effective rate was 87.5%. In the control group, 6 cases were markedly improved, 24 cases improved, 10 cases were ineffective, and the total effective rate was 75.0%. The total effective rate between the two groups, the difference was significant (P <0.05). Integrative medicine group clinical symptoms and signs better than the control group (P <0.05). Conclusion: The combination of traditional Chinese and Western medicine for the treatment of acute exacerbation of chronic obstructive pulmonary disease has a good clinical efficacy, and is superior to conventional Western medicine treatment.